SQI DIAGNOSTICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-100.00% | -100.00% |
| 2023 | SQI Diagnostics Announces Resignation of Wilmot L. Matthews as Director | CI |
| 2023 | Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc | CI |
Valuation
| Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 17.14 | 20.59 | 28.92 | 78.03 | 68.88 | 45.27 |
| Enterprise Value (EV) 1 | 18.19 | 21.2 | 28.71 | 80.54 | 71.41 | 59.95 |
| P/E ratio | -2.61 x | -2.29 x | -2.78 x | -7.94 x | -6.09 x | -2.42 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 17.7 x | 15.4 x | 15.3 x | 76.3 x | 75.1 x | 5.59 x |
| EV / Revenue | 18.8 x | 15.9 x | 15.2 x | 78.7 x | 77.9 x | 7.4 x |
| EV / EBITDA | -3.7 x | -3.31 x | -4.17 x | -10.8 x | -7.39 x | -5.75 x |
| EV / FCF | -5.82 x | -5.21 x | -8.92 x | -20.6 x | -11.8 x | -10 x |
| FCF Yield | -17.2% | -19.2% | -11.2% | -4.85% | -8.48% | -9.95% |
| Price to Book | 17.8 x | 10.7 x | 18.9 x | 45.5 x | 45.1 x | -4.61 x |
| Nbr of stocks (in thousands) | 103,875 | 158,407 | 231,341 | 305,992 | 362,530 | 393,635 |
| Reference price 2 | 0.1650 | 0.1300 | 0.1250 | 0.2550 | 0.1900 | 0.1150 |
| Announcement Date | 11/16/17 | 12/11/18 | 12/11/19 | 1/27/21 | 1/26/22 | 1/30/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.968 | 1.335 | 1.891 | 1.023 | 0.917 | 8.102 |
| EBITDA 1 | -4.921 | -6.411 | -6.883 | -7.488 | -9.657 | -10.42 |
| EBIT 1 | -5.408 | -6.858 | -7.365 | -7.892 | -10.04 | -13.85 |
| Operating Margin | -558.68% | -513.71% | -389.48% | -771.46% | -1,094.77% | -170.97% |
| Earnings before Tax (EBT) 1 | -5.929 | -7.437 | -8.021 | -8.571 | -10.56 | -18.52 |
| Net income 1 | -5.929 | -7.437 | -8.021 | -8.571 | -10.56 | -18.52 |
| Net margin | -612.5% | -557.08% | -424.17% | -837.83% | -1,151.25% | -228.62% |
| EPS 2 | -0.0632 | -0.0568 | -0.0450 | -0.0321 | -0.0312 | -0.0475 |
| Free Cash Flow 1 | -3.126 | -4.07 | -3.217 | -3.907 | -6.055 | -5.965 |
| FCF margin | -322.9% | -304.88% | -170.13% | -381.9% | -660.26% | -73.63% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/16/17 | 12/11/18 | 12/11/19 | 1/27/21 | 1/26/22 | 1/30/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.05 | 0.6 | - | 2.51 | 2.53 | 14.7 |
| Net Cash position 1 | - | - | 0.21 | - | - | - |
| Leverage (Debt/EBITDA) | -0.2136 x | -0.0942 x | - | -0.3353 x | -0.2622 x | -1.408 x |
| Free Cash Flow 1 | -3.13 | -4.07 | -3.22 | -3.91 | -6.05 | -5.97 |
| ROE (net income / shareholders' equity) | -299% | -516% | -466% | -527% | -649% | 447% |
| ROA (Net income/ Total Assets) | -66.9% | -87.4% | -76% | -68.8% | -73.2% | -94.2% |
| Assets 1 | 8.867 | 8.511 | 10.55 | 12.46 | 14.41 | 19.66 |
| Book Value Per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0 | -0.0200 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0100 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.1 | 0.26 | 0.17 | 0.15 | 1.5 | 1.31 |
| Capex / Sales | 10.02% | 19.1% | 8.94% | 14.76% | 164.01% | 16.14% |
| Announcement Date | 11/16/17 | 12/11/18 | 12/11/19 | 1/27/21 | 1/26/22 | 1/30/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -100.00% | 4.46M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- SQD.H Stock
- Financials SQI Diagnostics Inc.
